From:
$160.00
Prescription required
Symbicort (Budesonide, Formoterol): Uses, Dosage, Side Effects, and More
Reviewed by:
From:
$160.00
Prescription required
Symbicort is a prescription combination inhaler used to manage asthma and chronic obstructive pulmonary disease (COPD). It contains a corticosteroid to reduce airway inflammation and a long-acting bronchodilator to relax airway muscles, improving breathing. Used daily as maintenance therapy, Symbicort helps prevent asthma attacks and COPD flare-ups but is not intended for sudden breathing issues. It must be used exactly as prescribed and not for acute shortness of breath—use a rescue inhaler instead. Rinse your mouth with water after each use to help prevent oral thrush.
Your Prescription
Ready to Fill
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
Drug Facts
Generic name
Budesonide and Formoterol Fumarate Dihydrate
Brand names
Symbicort
Drug type
Combination inhaled corticosteroid (ICS) and long-acting beta2 agonist (LABA)
Controlled substance
Not a controlled medication
Dosage forms
Inhalation aerosol
Typical dosage
For asthma in adults and adolescents aged 12 years and older, the usual dose is 2 inhalations of 80/4.5 mcg or 160/4.5 mcg twice daily. In COPD (adults), the recommended dose is 2 inhalations of 160/4.5 mcg twice daily. Children ages 6–11 years may be prescribed 2 inhalations of 80/4.5 mcg twice daily, with dosing adjusted based on disease severity and prior therapy.
Basics
What Is Symbicort?
Symbicort is a combination inhaler containing budesonide and formoterol, prescribed to help control respiratory conditions such as asthma and COPD. Budesonide is an anti-inflammatory corticosteroid that reduces swelling and irritation in the airways, while formoterol is a bronchodilator that relaxes airway muscles to enhance airflow and ease breathing.
Together, the two components of Symbicort offer a dual therapeutic approach. By addressing both inflammation and constriction, Symbicort provides comprehensive management for individuals with persistent asthma or COPD.
Patients need to understand that while one component (budesonide) is a steroid, the medication as a whole is not simply a steroid treatment. It is a strategic combination designed to keep airways open consistently. This dual-action mechanism makes Symbicort effective for chronic management.
- Market Alert (Move to Generics): In early 2024, AstraZeneca discontinued brand-name Symbicort HFA in the U.S., transitioning patients to an authorized generic labeled budesonide/formoterol fumarate dihydrate, which contains the same medication and uses the same inhaler device. Some pharmacies may dispense Breyna, an FDA-approved generic with a slightly different inhaler design, so patients should review priming instructions carefully if switched.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
What Is Budesonide?
Budesonide is a synthetic corticosteroid (glucocorticoid) medication that helps reduce inflammation in the body. It works by binding to glucocorticoid receptors in cells and suppressing the release of inflammatory chemicals such as cytokines and prostaglandins. This action decreases swelling, irritation, and mucus production in affected tissues.
Medically, budesonide is used to treat various inflammatory and allergic conditions. Inhaled forms (like Pulmicort) are prescribed for asthma and chronic obstructive pulmonary disease (COPD), nasal sprays for allergic rhinitis or nasal polyps, and oral or rectal forms for inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
Because of its strong local anti-inflammatory effect and relatively low systemic absorption, budesonide often causes fewer side effects than other corticosteroids when used correctly.
What Is Formoterol?
Formoterol is a long-acting beta-agonist (LABA) bronchodilator used to help improve breathing in respiratory conditions such as asthma and COPD. It works by stimulating beta-2 receptors on the smooth muscle lining the airways, relaxing the smooth muscle. This leads to bronchodilation—wider air passages that make it easier for air to flow in and out of the lungs.
Formoterol has a rapid onset of action—often within minutes—along with a long duration of action, lasting up to 12 hours. This makes it useful for both maintenance therapy and ongoing symptom prevention. Because LABAs do not treat underlying inflammation, formoterol is most commonly used in combination with an inhaled corticosteroid like budesonide.
Indications
What Is Symbicort Used For?
Symbicort is primarily used for the long-term treatment of asthma and COPD (Chronic Obstructive Pulmonary Disease). It is essential for preventing symptoms such as wheezing, coughing, shortness of breath, and chest tightness.
Unlike some inhalers, Symbicort is not suitable for immediate relief during sudden asthma attacks or acute COPD exacerbations. Instead, it’s prescribed to manage respiratory conditions consistently over time.
- Major Clinical Update (Symbicort as Rescue Inhaler): Under 2025 GINA guidelines, Symbicort is commonly prescribed as Single Maintenance and Reliever Therapy (SMART) because its formoterol acts within 1–3 minutes, allowing the same inhaler to be used for daily control and rapid symptom relief. This approach provides a simultaneous steroid boost with each rescue dose to treat airway inflammation. If you are on the SMART protocol, your clinician may instruct you to stop using a separate albuterol inhaler.
Mechanism
How Does Symbicort Work?
Symbicort operates through the synergistic action of budesonide and formoterol. Budesonide, a corticosteroid, effectively reduces inflammation in the respiratory tract, thereby reducing swelling and irritation over time.
This action helps alleviate symptoms such as persistent coughing and breathing difficulties associated with chronic respiratory diseases.
How Long Does Symbicort Take to Work?
While the bronchodilator formoterol starts working relatively quickly, improving breathing within approximately 15 minutes, the steroid budesonide requires continuous use to reduce inflammation effectively.
Patients often notice gradual improvements in symptoms, such as reduced wheezing and easier breathing, with ongoing Symbicort treatment. Full symptom relief and improvement in lung function may take one to two weeks of consistent use.
Symbicort should not be used for sudden-onset symptoms due to the systemic effects and budesonide’s onset time. The medication’s design encourages consistent use for preventive respiratory care.
Dosage
Symbicort Dosages and Administration
Symbicort is delivered via a metered-dose inhaler, and proper technique is essential to ensure the medication reaches the airways effectively.
Dosage Guidelines
Most patients are prescribed two inhalations twice daily, ideally taken at the exact times each day to maintain consistent therapeutic levels. This regular schedule supports ongoing symptom control and helps prevent asthma or COPD flare-ups.
Administration Guidelines
Before use, the inhaler should be shaken well, and patients should exhale fully before placing the mouthpiece between their lips. After pressing down to release a dose, patients should inhale deeply and hold their breath for several seconds to ensure full absorption.
Rinsing the mouth afterward is recommended to decrease the risk of irritation or oral thrush associated with inhaled corticosteroids. Patients should not exceed the prescribed number of inhalations and should consult their provider if symptoms worsen or if the rescue inhaler is needed more frequently than usual.
Proper Device Care (Priming Required): Symbicort must be primed before first use by shaking for 5 seconds and by spraying 4 test sprays away from the face; re-priming with 2 sprays is required if unused for more than 7 days or if dropped; failure to prime can result in inconsistent or inadequate dosing.
Get The Right Dose For Less
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Symbicort Side Effects and Risks
While Symbicort is generally highly effective for long-term respiratory control, it can cause side effects that vary from person to person. Understanding these effects helps patients use the medication safely and recognize when medical follow-up may be needed.
Common Side Effects
Most side effects associated with Symbicort are mild and temporary, especially when proper inhaler technique is followed.
- Throat Irritation or Hoarseness: This is one of the most common side effects and occurs when medication particles deposit in the mouth and throat rather than the lungs. It can cause hoarseness, sore throat, or dryness. These symptoms are usually mild and improve by rinsing the mouth and spitting after each use to remove any residual medication.
- Cough: A mild, short-lived cough can occur immediately after inhalation as the airways react to the medication. This typically decreases over time as the body adjusts. Using proper inhalation technique and ensuring a smooth dose delivery can minimize coughing.
- Headaches: Some users experience mild headaches, especially during the first few days of treatment. These are generally temporary and subside as the body acclimates to the medication. Staying hydrated and using the inhaler at consistent intervals can help reduce this effect.
These side effects are typically manageable and do not require discontinuing therapy. However, if symptoms persist or interfere with daily activities, patients should speak with their healthcare provider about adjusting their treatment plan or evaluating inhaler technique.
Serious Side Effects
While uncommon, some more serious side effects can occur with Symbicort, particularly if it is used incorrectly or in higher-than-recommended doses.
- Increased Blood Pressure or Heart Rate: The formoterol component (a beta₂-agonist) can sometimes cause temporary increases in heart rate or blood pressure, particularly in patients with hypertension or cardiovascular disease. Periodic monitoring of blood pressure and heart rate is advised, and any new or worsening palpitations, chest pain, or dizziness should be promptly reported to a provider.
- Back Pain: Some individuals report back or muscle pain during treatment. While often mild, persistent or severe pain should be evaluated to rule out other causes and ensure it is not related to systemic effects.
- Oral Thrush (Candidiasis): The budesonide component can suppress local immune defenses in the mouth, leading to oral thrush. Symptoms include white patches, soreness, or difficulty swallowing. Rinsing the mouth and gargling with water (without swallowing) after every inhalation greatly reduces this risk.
Prompt medical attention is recommended if symptoms are severe or do not improve.
Additional Considerations
- Respiratory Infection & COPD Pneumonia Risk: Symbicort’s corticosteroid component may slightly increase the risk of upper respiratory infections or sore throat, and in patients with COPD, long-term use is associated with a small but meaningful increase in pneumonia risk. Patients should monitor for worsening cough, fever, increased or discolored mucus, maintain good oral hygiene, and seek medical care promptly.
- Tremors or Nervousness: The formoterol component may occasionally cause mild tremors, restlessness, or nervousness, particularly at higher doses. These effects are usually short-lived and resolve on their own.
- Adrenal Suppression (Rare): Long-term use of inhaled corticosteroids at high doses may affect the body’s natural hormone balance, leading to adrenal suppression. This risk is minimal at standard doses but underscores the importance of not exceeding prescribed amounts.
Weight Gain and Metabolic Concerns
Significant weight gain is not commonly associated with Symbicort. Because budesonide is inhaled, systemic absorption is low compared with oral steroids, greatly reducing metabolic side effects.
In rare cases—particularly with high doses or long-term use—patients may experience mild weight changes, fluid retention, or subtle metabolic effects, especially if using other corticosteroids. The formoterol component may cause temporary increases in heart rate or blood pressure, which are usually mild.
Routine monitoring, a healthy lifestyle, and regular follow-up help ensure ongoing safety, and any concerning changes can be addressed through dose adjustment or supportive strategies.
Interactions
Symbicort Interactions
Certain medications can interact with Symbicort, altering its effects or increasing the risk of side effects. Because of this, patients need to inform their healthcare provider of all medications, supplements, and over-the-counter products they use.
Drug Interactions
- Albuterol: A short-acting beta₂-agonist (SABA) used for quick relief during acute asthma or COPD flare-ups, albuterol is safe to use alongside Symbicort, which provides long-term symptom control. It acts within minutes to relieve bronchospasms, while Symbicort maintains airway dilation and reduces inflammation over time. However, excessive use—such as needing it multiple times daily—may signal that asthma or COPD is not well controlled, and the treatment plan should be reviewed.
- Spiriva: Spiriva is a long-acting muscarinic antagonist (LAMA) that helps open airways by relaxing smooth muscles in the lungs. When used together with Symbicort, this combination can offer enhanced symptom control for COPD patients by targeting different pathways of airway constriction. However, combining multiple inhalers can sometimes increase the risk of dry mouth, throat irritation, or dizziness, so this approach should always be done under medical supervision.
- Beta-Blockers: Beta-blockers, used for heart conditions or high blood pressure, can counteract the effects of formoterol, the bronchodilator in Symbicort. This may reduce the medication’s ability to open airways, making breathing more difficult. When beta-blockers are necessary, providers may opt for cardioselective agents (such as metoprolol) and closely monitor lung function to minimize the risk of interactions.
- Antifungal and Antiviral Medications: These drugs can inhibit CYP3A4, an enzyme responsible for metabolizing budesonide. This may lead to higher budesonide levels in the bloodstream, increasing the risk of systemic corticosteroid effects such as adrenal suppression, weight gain, or elevated blood sugar. In such cases, dose adjustments or close monitoring by a healthcare provider are recommended.
- Other Bronchodilators or Stimulants: Combining Symbicort with additional bronchodilators, such as theophylline or other LABAs, can increase the risk of tremors, palpitations, or elevated heart rate. This should only be done when prescribed and supervised by a healthcare professional.
By maintaining open communication with healthcare providers and regularly reviewing all medications, patients can safely integrate Symbicort into their treatment plan to achieve effective, stable asthma or COPD control.
Contraindications
Symbicort Contraindications
Symbicort (budesonide/formoterol) is widely regarded as a safe and effective treatment for patients with asthma and chronic obstructive pulmonary disease (COPD). However, there are specific medical conditions and sensitivities where its use may pose a risk.
Absolute Contraindications
- Allergies or Hypersensitivity: Individuals who are allergic to budesonide, formoterol, or any inactive ingredient in Symbicort should not use this medication. Allergic reactions may present as rash, itching, swelling of the face or throat, wheezing, or difficulty breathing and require immediate medical attention. A known history of hypersensitivity to other corticosteroids or long-acting beta₂-agonists (LABAs) may also increase risk.
- Acute Bronchospasm or Severe Asthma Attacks: Symbicort is not designed for emergency use or to relieve sudden breathing problems. It acts gradually to control and prevent symptoms, but does not work fast enough to treat an acute asthma attack or sudden COPD flare-up. In these cases, a short-acting bronchodilator (rescue inhaler) such as albuterol should be used for immediate relief. Patients should keep their rescue inhaler accessible and seek urgent care if symptoms do not improve.
- Severe Liver Impairment: Because budesonide is metabolized in the liver, patients with significant hepatic dysfunction may experience higher drug levels in the bloodstream, increasing the risk of systemic corticosteroid side effects such as adrenal suppression or hormonal imbalance. These individuals may require lower doses or additional monitoring to ensure safety and proper medication clearance.
- Cardiovascular Conditions: The formoterol component of Symbicort can affect the cardiovascular system, particularly at high doses. Patients with a history of heart rhythm disturbances (arrhythmias), hypertension, ischemic heart disease, or heart failure should use this medication with caution. Formoterol may cause increased heart rate, palpitations, or elevated blood pressure, and periodic cardiovascular monitoring is recommended for these patients.
- Systemic Infections: Because budesonide is a corticosteroid, it can suppress immune function, potentially worsening or masking the symptoms of infections. Individuals with untreated systemic fungal, bacterial, viral, or parasitic infections should avoid using Symbicort until the infection is controlled. This includes infections such as tuberculosis (active or latent) or herpes simplex infection of the eye.
Additional Considerations
While not absolute contraindications, the following conditions warrant careful assessment and monitoring before and during Symbicort use:
- Endocrine disorders (such as thyroid dysfunction or diabetes), as well as corticosteroids, can affect blood sugar levels and hormone balance.
- Bone health concerns, since long-term corticosteroid use may contribute to osteoporosis or decreased bone density.
- Ocular conditions like glaucoma or cataracts, as corticosteroids, may worsen or accelerate these eye disorders.
- Pregnancy and breastfeeding, where the benefits and risks should be carefully evaluated by a healthcare provider.
By maintaining open communication with their healthcare team, patients can use Symbicort safely and effectively while minimizing potential risks and ensuring optimal respiratory control.
Ready to Start Saving?
No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.
Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.
Frequently Asked Questions (FAQs)
Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.
Administration & Dosage
Symbicort is administered using an aerosol inhaler that delivers a metered dose of medication. Before each use, shake the inhaler well, then remove the mouthpiece cover. Exhale fully to prepare your lungs for the dose. Place the mouthpiece between your teeth and seal your lips around it. Press down on the canister while inhaling slowly and deeply through your mouth. Hold your breath for about 10 seconds to allow the medication to settle in your lungs. Exhale gently. Follow the same steps for the second inhalation if prescribed twice daily as directed by your doctor.
Symbicort is not a dry powder inhaler. It is an aerosol inhaler that delivers medication as a mist. The aerosol form ensures a specific dose of medication is inhaled with each use, unlike dry powder inhalers.
Typically, Symbicort is taken as 2 inhalations twice a day, once in the morning and once in the evening, with a 12-hour interval between doses. However, your healthcare provider might adjust the dosage depending on your health condition and response to the treatment.
Symbicort is not intended for use as a rescue inhaler. It should not be used to relieve sudden asthma symptoms or acute COPD flare-ups. Quick-relief or rescue inhalers, rather than Symbicort, should be used for acute attacks to provide fast-acting relief.
Symbicort is designed for long-term asthma and COPD management, helping maintain ongoing symptom control. The duration of its use will depend on your condition and your response to treatment. Your doctor will regularly evaluate your condition and decide how long Symbicort should be continued as part of your treatment plan.
Store Symbicort at room temperature in a dry place, away from direct light and moisture. Do not expose the inhaler to freezing temperatures. Always ensure the inhaler cap is securely replaced after use to maintain device hygiene and effectiveness. Avoid storing it in high temperatures, such as in a car on a hot day.
Uses & Mechanism of Action
Symbicort is primarily used to manage asthma in patients 6 years and older and chronic obstructive pulmonary disease (COPD) in adults. It helps control asthma symptoms and prevent flare-ups, reducing hospital visits due to severe asthma attacks. It’s also effective in managing COPD by decreasing exacerbations and improving airflow in the lungs.
Symbicort is a combination medication that reduces inflammation in the airways and improves breathing. It helps widen air passages by targeting two primary symptoms of respiratory conditions: inflammation and airway constriction. Its dual-action not only relieves symptoms but also helps prevent them from worsening.
Symbicort combines two key medications: budesonide and formoterol. Budesonide is a corticosteroid that reduces inflammation and swelling in the airways. At the same time, formoterol is a long-acting beta-agonist (LABA) that helps relax and open up the muscles around the airways, making breathing easier. This combination provides both immediate symptom relief and long-term control of inflammation.
Symbicort contains budesonide, which is a corticosteroid. This component of the medication plays a crucial role in reducing inflammation, helping to control symptoms and prevent the progression of respiratory diseases.
Many patients experience some improvement in their symptoms shortly after using Symbicort, often within 15 minutes, due to the rapid action of formoterol. However, the full therapeutic effects, particularly from the anti-inflammatory benefits of budesonide, may take a week or two to become noticeable.
Symbicort functions as a bronchodilator in part because it includes formoterol, which helps to relax and open the airways in the lungs. This bronchodilation makes breathing easier by increasing airflow and reducing resistance in the respiratory airways.
Side Effects & Safety
Some common side effects of Symbicort include throat irritation, headache, nausea, and sinusitis. Users may also experience coughing, back pain, or changes in voice, such as hoarseness. It is crucial to report any severe or persistent side effects to your healthcare provider to ensure your treatment is safe and effective.
Weight gain is not a typical side effect of Symbicort, though it has been associated with corticosteroids in general. Long-term use of corticosteroids such as budesonide can lead to weight gain in some individuals due to changes in metabolic rate or increased appetite.
While not commonly associated with high blood pressure, patients with a history of hypertension should consult with their healthcare provider about their specific risks. If you experience any unusual symptoms while using Symbicort, it's important to seek medical advice.
While back pain is a less common side effect of Symbicort, it can occur in some individuals. This might be related to the drug's muscle-relaxant properties, which affect musculoskeletal tissues. If you experience significant or persistent back pain, discussing this with your healthcare provider can help determine if Symbicort is the cause.
Thrush, a fungal infection of the mouth or throat, can occur with the use of inhaled corticosteroids such as budesonide. To reduce the risk of thrush, patients should rinse their mouth with water and spit it out after using the inhaler. Using a spacer device with the inhaler can also help minimize exposure to the oral cavity.
By helping to reduce inflammation and open airways, Symbicort may facilitate the loosening and coughing up of phlegm. This action can help improve breathing and reduce chest congestion over time, particularly in patients with COPD.
Interactions & Contraindications
Albuterol, a short-acting bronchodilator, can be used alongside Symbicort as a rescue inhaler for quick relief of sudden breathing issues. Always follow your healthcare provider's advice on the simultaneous use of these medications to ensure safety and effectiveness.
Antihistamines are generally safe to use with Symbicort. However, it's essential to confirm with your healthcare provider, especially if you are managing other conditions or taking additional medications, to avoid possible interactions that could affect treatment outcomes.
In certain cases, Symbicort and Spiriva may be prescribed together for severe COPD management. They work in complementary ways, using different mechanisms to improve lung function and manage symptoms. Consulting with a healthcare provider is vital to identifying if this combination is appropriate for your specific needs.
Patients using Symbicort should avoid exposure to respiratory triggers such as smoke or allergens that may worsen asthma or COPD symptoms. Following any lifestyle or dietary advice from your healthcare provider will also help improve the management of your condition.
There are no specific dietary restrictions when using Symbicort, so you can eat after using your inhaler. Maintaining a well-balanced diet will help manage your overall health while using Symbicort as part of your treatment regimen.
Generic & Alternatives
A generic version of Symbicort that contains the same active ingredients, budesonide and formoterol, is available. This can be a more cost-effective option while providing the same therapeutic benefits as the branded version.
Generic options such as the budesonide/formoterol combination can be less expensive than the branded Symbicort. Other alternatives, depending on your specific condition, might include medications like Advair. Always consult your healthcare provider to determine the best, most cost-effective option for your situation.
Breyna is a generic equivalent of Symbicort, containing the same active ingredients and offering similar benefits for the treatment of asthma and COPD. It has been approved for use at the same level of effectiveness as the brand-name medication.
Symbicort and Advair are both inhalers used to treat asthma and COPD, but contain different active ingredient combinations. Advair includes fluticasone and salmeterol, while Symbicort contains budesonide and formoterol. Your healthcare provider can guide you in choosing the most suitable option based on your medical condition and response to treatment.
The cost of Symbicort without insurance can vary widely, often ranging from a couple of hundred to several hundred dollars. Prices may be lower if opting for the generic version or when using pharmacy discount programs.
Symbicort coverage is often available under Medicare Part D or Medicare Advantage plans that include prescription drug coverage. However, individual plan details can vary, so it's advisable to consult your specific Medicare plan provider to confirm coverage details.
Disclaimer
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
